Bravida Medical
Private Company
Total funding raised: $25M
Overview
Bravida Medical is a commercial-stage medical device company building a portfolio of clinically-proven products for infection prevention and advanced wound care. Its core technology leverages antimicrobial silver and other agents across dressings, cleansers, and securement devices targeting high-burden areas like surgical sites, vascular access, burns, and urology. The company demonstrates commercial traction, impacting millions of patient and healthcare professional lives annually, and actively publishes clinical evidence to support its products' use in complex care settings such as ventricular assist device (VAD) driveline and ECMO cannula site management.
Technology Platform
Application of antimicrobial agents (silver, chlorhexidine) in specialized dressings, cleansers, and securement devices for infection prevention and wound management.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Bravida competes in crowded segments against major players like 3M, Smith & Nephew, ConvaTec, and Coloplast in wound care and infection prevention. Its differentiation hinges on specialized applications (e.g., VAD/ECMO securement), its specific silver-plated nylon technology, and a focused clinical evidence strategy targeting high-acuity complications.